Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use SILIQ safely and effectively. See full prescribing information for SILIQ. SILIQ® (brodalumab) injection, for subcutaneous use Initial U.S. Approval: 2017
Medication labelWhy this: Advisory · dailymed-prescription
SILIQ® (brodalumab) is indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy and have failed to respond or have lost response to other systemic therapies.
- generic_name
- brodalumab
- product_names
- Brodalumab
- ndc
- 0187-0004, 0187-0004-00, 0187-0004-02, 0187-0004-03, 0187-0004-04
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en